Translocator protein (18 kDa) mapping with [125I]-CLINDE in the quinolinic acid rat model of excitotoxicity: A longitudinal comparison with microglial activation, astrogliosis, and neuronal death

Molecular Imaging

Volumn 13, Issue 2, 2014, Pages

  Arlicot, Nicolas ^a,b   Tronel, Claire ^a,b   Bodard, Sylvie ^a,b   Garreau, Lucette ^a,b   De La Crompe, Brice ^a,b   Vandevelde, Inge ^a,b   Guilloteau, Denis ^a,b   Antier, Daniel ^a,b   Chalon, Sylvie ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b CHU BRETONNEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINS; PYRIDINE; RADIOGRAPHY;

ANTI-INFLAMMATORIES; DIFFERENTIAL EFFECT; IMMUNOHISTOCHEMICAL STUDIES; IMMUNOREACTIVITIES; INFLAMMATORY REACTION; MICROGLIAL ACTIVATIONS; NEURODEGENERATION; NEUROINFLAMMATION;

NEURONS;

4 AMINOBUTYRIC ACID RECEPTOR; 6-CHLORO-2-(4'-IODOPHENYL)-3-(N,N-DIETHYL)IMIDAZO(1,2-A)PYRIDINE-3-ACETAMIDE; FUSED HETEROCYCLIC RINGS; NEUROTOXIN; QUINOLINIC ACID; RADIOACTIVE IODINE;

ANIMAL; ASTROCYTE; CELL DEATH; CHEMISTRY; DRUG EFFECTS; MALE; METABOLISM; MICROGLIA; MOLECULAR IMAGING; PROCEDURES; RADIOASSAY; RAT; WISTAR RAT;

ANIMALS; ASTROCYTES; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL DEATH; IODINE RADIOISOTOPES; MALE; MICROGLIA; MOLECULAR IMAGING; NEUROTOXINS; QUINOLINIC ACID; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, GABA;

EID: 84898031888     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2013.00075     Document Type: Article

References (38)

1. Loftis JM, Janowsky A. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 2003;97:55-85, doi:10.1016/S0163-7258(02)00302-9.
2. Glass CK, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration. Cell 2010;140:918-34, doi:10.1016/j.cell.2010.02.016.
3. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-8, doi:10.1016/0166-2236(96)10049-7.
4. Alexi T, Borlongan CV, Faull RL, et al. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol 2000;60:409-70, doi:10.1016/S0301-0082(99)00032-5.
5. Beal MF, Kowall NW, Ellison DW, et al. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 1986;321:168-71, doi:10.1038/321168a0.
6. Schwarcz R, Whetsell WO Jr, Mangano RM. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983;219:316-8, doi:10.1126/science.6849138.
7. Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996;87:493-506, doi:10.1016/S0092-8674(00) 81369-0.
8. von Horsten S, Schmitt I, Nguyen HP, et al. Transgenic rat model of Huntington's disease. Hum Mol Genet 2003;12:617-24, doi:10.1093/hmg/ddg075.
9. Leaver KR, Reynolds A, Bodard S, et al. Effects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatum. ACS Chem Neurosci 2012;3:114-9, doi:10.1021/cn200099e.
10. Ramaswamy S, Shannon KM, Kordower JH. Huntington's disease: pathological mechanisms and therapeutic strategies. Cell Transplant 2007;16:301-12.
11. Heneka MT, Rodriguez JJ, Verkhratsky A. Neuroglia in neurodegeneration. Brain Res Rev 2010;63:189-211, doi:10.1016/j.brainresrev.2009.11.004.
12. Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 2001;166:7527-33.
13. Satoh JI, Kawana N, Yamamoto Y, et al. A survey of TREM2 antibodies reveals neuronal but not microglial staining in formalin-fixed paraffin-embedded postmortem Alzheimer's brain tissues. Alzheimers Res Ther 2013;5:30, doi:10.1186/alzrt184.
14. Wake H, Moorhouse AJ, Miyamoto A, Nabekura J. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci 2013;36:209-17, doi:10.1016/j.tins.2012.11.007.
15. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006;27:402-9, doi:10.1016/j.tips.2006.06.005.
16. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci U S A 1992;89:3170-4, doi:10.1073/pnas.89.8.3170.
17. Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther 2008;118:1-17, doi:10.1016/j.pharmthera.2007.12.004.
18. Choi IY, Lee SP, Guilfoyle DN, Helpern JA. In vivo NMR studies of neurodegenerative diseases in transgenic and rodent models. Neurochem Res 2003;28:987-1001, doi:10.1023/A:1023370104289.
19. Arlicot N, Katsifis A, Garreau L, et al. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation. Eur J Nucl Med Mol Imaging 2008;35:2203-11, doi:10.1007/s00259-008-0834-x.
20. Belloli S, Moresco RM, Matarrese M, et al. Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo PET imaging of neurodegeneration. Neurochem Int 2004;44:433-40, doi:10.1016/j. neuint.2003.08.006.
21. Dobrossy MD, Braun F, Klein S, et al. [18F]Desmethoxyfallypride as a novel PET radiotracer for quantitative in vivo dopamine D2/D3 receptor imaging in rat models of neurodegenerative diseases. Nucl Med Biol 2012;39:1077-80, doi:10.1016/j.nucmedbio.2012.04.003.
22. James ML, Fulton RR, Vercoullie J, et al. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization J Nucl Med 2008;49:814-22, doi:10.2967/jnumed.107.046151.
23. Moresco RM, Lavazza T, Belloli S, et al. Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation. Eur J Nucl Med Mol Imaging 2008;35:704-15, doi:10.1007/s00259-007-0651-7.
24. Mattner F, Katsifis A, Staykova M, et al. Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis. Eur J Nucl Med Mol Imaging 2005;32:557-63, doi:10.1007/s00259-004-1690-y.
25. Arlicot N, Petit E, Katsifis A, et al. Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE. Eur J Nucl Med Mol Imaging 2010;37:2371-80, doi:10.1007/s00259-010-1598-7.
26. Dedeurwaerdere S, Callaghan PD, Pham T, et al. PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. EJNMMI Res 2012;2:60, doi:10.1186/2191-219X-2-60.
27. Tronel C, Rochefort GY, Arlicot N, et al. Oxidative stress is related to the deleterious effects of heme oxygenase-1 in an in vivo neuroinflammatory rat model. Oxid Med Cell Longev 2013 2013. 264935.
28. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press;1986.
29. Bolton SJ, Perry VH. Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats. Exp Neurol 1998;154:231-40, doi:10.1006/exnr.1998.6927.
30. Ryu JK, Choi HB, McLarnon JG. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum. Neurobiol Dis 2005;20:550-61, doi:10.1016/j.nbd. 2005.04.010.
31. Maeda J, Higuchi M, Inaji M, et al. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res 2007 1157. 100-11.
32. Venneti S, Lopresti BJ, Wiley CA. The peripheral benzodiazepine receptor (translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol 2006;80:308-22, doi:10.1016/j.pneurobio.2006.10.002.
33. Collin T, Arvidsson A, Kokaia Z, et al. Quantitative analysis of the generation of different striatal neuronal subtypes in the adult brain following excitotoxic injury. Exp Neurol 2005;195:71-80, doi:10.1016/j.expneurol.2005.03. 017.
34. Gordon RJ, Tattersfield AS, Vazey EM, et al. Temporal profile of subventricular zone progenitor cell migration following quinolinic acid-induced striatal cell loss. Neuroscience 2007;146:1704-18, doi:10.1016/j.neuroscience. 2007.03.011.
35. Tattersfield AS, Croon RJ, Liu YW, et al. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease. Neuroscience 2004;127:319-32, doi:10.1016/j.neuroscience.2004.04.061.
36. Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-affinity [3H]diazepam binding. Proc Natl Acad Sci U S A 1977;74:3805-9, doi:10.1073/pnas.74.9.3805.
37. Maeda J, Suhara T, Zhang MR, et al. Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: an imaging tool for glial cells in the brain. Synapse 2004;52:283-91, doi:10.1002/syn.20027.
38. Kropholler MA, Boellaard R, Schuitemaker A, et al. Evaluation of reference tissue models for the analysis of [11C](R)-PK11195 studies. J Cereb Blood Flow Metab 2006;26:1431-41, doi:10.1038/sj.jcbfm.9600289.